All articles by Anthony King – Page 14
-
FeatureNew MRI contrast agents
With rising concerns over gadolinium, Anthony King looks at the alternatives under development
-
NewsPharma giants commit to tackling antimicrobial resistance
Plan to tackle superbugs includes changes to manufacturing and sales incentives
-
BusinessBayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
BusinessSadara cracker eyes richer chemical rewards
Joint venture between Dow and Saudi Aramco will target added value plastics and speciality chemicals
-
NewsBrexit referendum storm shakes European Research Council
Europe’s premier science council’s mission at risk with the impending loss of two scientific powerhouses
-
NewsAntibiotic partnership plans accelerated drug development
Public–private venture will invest $350 million over five years but there are warnings that much more money is still needed
-
NewsReport takes aim at research assessment’s cost and distortions
Head of British Academy recommends more flexibility for the Research Excellence Framework to end ‘gaming’ of the exercise
-
ResearchNew antibiotic picked from nose bacteria
Discovery suggests human microbiome may be an untapped source of antimicrobial compounds
-
ResearchKamikaze bacteria travel deep inside tumours to deliver deadly cargo
Engineered bacteria in tandem with chemotherapy show promise in mouse model of cancer
-
BusinessBrexit uncertainty ripples across regulation
What might leaving the EU mean for medicines regulation, the Unified Patent Court, and the UK’s participation in Reach?
-
ResearchModel hints at prebiotic chemistry on Titan
Saturn’s largest moon may be rich in hydrogen cyanide based polymers
-
BusinessSanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
NewsWorld faces tough challenge turning words into action on antibiotic resistance
Countries are waking up to the challenge of ‘superbugs’ but agreeing a way forward will be tricky
-
NewsAudience reactions alter cinema atmosphere
The emotional content of a film affects the skin and breath volatiles given off by cinema goers
-
-
BusinessAbbot boosts heart devices with St Jude buyout
Medical devices consolidation continues with $25bn deal, but Abbott expresses concerns over proposed Alere merger
-
ResearchEarthly xenon’s asteroid origins reveal planet’s genesis
Discovery that atmospheric xenon is unrelated to that in the mantle hints at two separate extra-terrestrial ‘deliveries’ of the element
-
-
BusinessUS treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
News
Irish institute in hot water with university ranking agency
Quacquarelli Symonds unhappy with emails sent to academics asking them to take part in survey